Prognostic value of urokinase plasminogen activator receptor (uPAR) and neutrophil CD64 expression in acute respiratory distress syndrome patients

A. Attia, H. Hassan, M. Elsammak (Zagazig, Egypt; Dammam, Saudi Arabia)

Source: Annual Congress 2013 –Acute respiratory failure, ARDS and severe COPD exacerbations
Session: Acute respiratory failure, ARDS and severe COPD exacerbations
Session type: Thematic Poster Session
Number: 2430
Disease area: Respiratory critical care

Congress or journal article abstractE-poster

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
A. Attia, H. Hassan, M. Elsammak (Zagazig, Egypt; Dammam, Saudi Arabia). Prognostic value of urokinase plasminogen activator receptor (uPAR) and neutrophil CD64 expression in acute respiratory distress syndrome patients. Eur Respir J 2013; 42: Suppl. 57, 2430

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Usefulness of a selective neutrophil elastase inhibitor and a recombinant human soluble thrombomodulin in patients with ARDS and DIC
Source: Annual Congress 2013 –Acute respiratory failure, ARDS and severe COPD exacerbations
Year: 2013


Del-1 reduces endotoxin-induced polymorphonuclear leukocytes adhension and mortality
Source: Annual Congress 2013 –Experimental models in critical care
Year: 2013


LATE-BREAKING ABSTRACT: The metalloproteinase ADAM8 promotes acute and chronic lung inflammation
Source: International Congress 2015 – Inflammation and remodelling in lung disease
Year: 2015

Ventilation-induced neutrophil infiltration depends on nuclear factor-kB and NF-kB repressing factor
Source: Annual Congress 2013 –Novel mechanisms in lung injury
Year: 2013

Preoperative statin administration does not protect against early postoperative acute respiratory distress syndrome (ARDS): A retrospective cohort study
Source: Annual Congress 2013 –Acute respiratory failure, ARDS and severe COPD exacerbations
Year: 2013


Markers of poor outcome in patients with acute hypoxemic respiratory failure
Source: International Congress 2014 – ICU outcomes, sepsis and infections
Year: 2014

Outcome of acute drug-induced pneumonias in ICU
Source: Annual Congress 2013 –Diffuse parenchymal lung disease II
Year: 2013


Heparin effect in pulmonary cell populations in an in-vitro model of acute lung injury
Source: International Congress 2016 – Studies in airway cell biology
Year: 2016


Can procalcitonin or C-reactive protein predict supporative lung complications and ARDS at severe community-acquired pneumonia (CAP)?
Source: International Congress 2016 – Community-acquired pneumonia: from prevention to treatment
Year: 2016


Methotrexate reduces acute lung injury in a murine model of sepsis
Source: International Congress 2016 – Infections, sepsis, and pulmonary embolism
Year: 2016


Soluble urokinase-type plasminogen activator receptor in monitoring of treatment response in acute exacerbation of chronic obstructive pulmonary disease
Source: International Congress 2017 – Current challenges in COPD evaluation
Year: 2017

Relationship of circulating soluble urokinase plasminogen activator receptor (suPAR) levels to disease control in asthma and asthmatic pregnancy
Source: International Congress 2014 – Systemic biomarkers for airway diseases
Year: 2014


Soluble urokinase-type plasminogen activator receptor is a novel biomarker predicting acute exacerbation in COPD
Source: International Congress 2015 – Non-exhaled biomarkers in the assessment of airways disease
Year: 2015

Heparin effect in alveolar cells and macrophages in an acute lung injury model
Source: International Congress 2015 – Novel insights into the pathobiology of acute lung injury
Year: 2015

The role of SIRT1 in LPS-induced lung endothelial barrier dysfunction and lung injury in vivo
Source: International Congress 2016 – Molecular targets in pulmonary disease
Year: 2016


Obesity modulates the alveolar macrophage response
Source: International Congress 2015 – Novel insights into the pathobiology of acute lung injury
Year: 2015

Acute respiratory distress syndrome in patients admitted for community-acquired pneumonia
Source: International Congress 2014 – ARDS, skeletal muscles, physiology and weaning
Year: 2014


LATE-BREAKING ABSTRACT: Activation of MTOR in pulmonary epithelium promotes LPS-induced acute lung injury
Source: International Congress 2016 – Novel mechanisms and therapeutic targets in acute and chronic inflammatory disease
Year: 2016



Down-regulation of RIP140 can prevent LPS-induced inflammation and acute lung injury in mice via PPARγ
Source: International Congress 2015 – Novel insights into the pathobiology of acute lung injury
Year: 2015

Drug-associated acute respiratory distress syndrome: A prospective observational cohort study
Source: International Congress 2015 – IPF: clinical aspects II
Year: 2015